Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Hematologic Neoplasms × Clofarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Blast Crisis 1

Interventions

Exercise 1 Dosage Forms 1 Clofarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00028418 2015-03-25

Clofarabine in Chronic Lymphocytic Leukemia

FDA Office of Orphan Products Development

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡